5918 Federal Register / Vol. 90, No. 11 / Friday, January 17, 2025 / Notices 

poverty guidelines are not defined for 

Puerto Rico or other outlying 

jurisdictions. In cases in which a 

Federal program using the poverty 

guidelines serves any of those 

jurisdictions, the Federal office that 

administers the program is generally 

responsible for deciding whether to use 

the contiguous-states-and-DC guidelines 

for those jurisdictions or to follow some 

other procedure. 

Due to confusing legislative language 

dating back to 1972, the poverty 

guidelines sometimes have been 

mistakenly referred to as the ‘‘OMB’’ 

(Office of Management and Budget) 

poverty guidelines or poverty line. In 

fact, OMB has never issued the 

guidelines; the guidelines are issued 

each year by the Department of Health 

and Human Services. The poverty 

guidelines may be formally referenced 

as ‘‘the poverty guidelines updated 

periodically in the Federal Register by 

the U.S. Department of Health and 

Human Services under the authority of 

42 U.S.C. 9902(2).’’ 

Some Federal programs use a 

percentage multiple of the guidelines 

(for example, 125 percent or 185 percent 

of the guidelines), as noted in relevant 

authorizing legislation or program 

regulations. Non-Federal organizations 

that use the poverty guidelines under 

their own authority in non-Federallyfunded activities also may choose to use 

a percentage multiple of the guidelines. 

The poverty guidelines do not make a 

distinction between farm and non-farm 

families, or between aged and non-aged 

units. (Only the Census Bureau poverty 

thresholds have separate figures for aged 

and non-aged one-person and twoperson units.) 

This notice does not provide 

definitions of such terms as ‘‘income’’ or 

‘‘family’’ as there is considerable 

variation of these terms among programs 

that use the poverty guidelines. The 

legislation or regulations governing each 

program define these terms and 

determine how the program applies the 

poverty guidelines. In cases where 

legislation or regulations do not 

establish these definitions, the entity 

that administers or funds the program is 

responsible to define such terms as 

‘‘income’’ and ‘‘family.’’ Therefore, 

questions such as net or gross income, 

counted or excluded income, or 

household size should be directed to the 

entity that administers or funds the 

program. 

Xavier Becerra, 

Secretary, Department of Health and Human 

Services. 

[FR Doc. 2025–01377 Filed 1–16–25; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cardiovascular 

and Respiratory Sciences Integrated 

Review Group Integrative Myocardial 

Physiology/Pathophysiology B Study 

Section. 

Date: February 12–13, 2025. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive 

,Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kirk E. Dineley, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

806E, Bethesda, MD 20892, (301) 867– 

5309, dineleyke@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated 

Review Group Drug and Biologic 

Therapeutic Delivery Study Section. 

Date: February 18–19, 2025. 

Time: 9:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Janice Duy, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892, 301–594–3139, janice.duy@

nih.gov. 

Name of Committee: Oncology 1- 

Basic Translational Integrated Review 

Group Cancer Genetics Study Section. 

Date: February 18–19, 2025. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications.. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Juraj Bies, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 

4158, MSC 7806, Bethesda, MD 20892, 

301 435 1256, biesj@mail.nih.gov.. 

Name of Committee: Biobehavioral 

and Behavioral Processes Integrated 

Review Group; Biobehavioral 

Regulation, Learning and Ethology 

Study Section. 

Date: February 18–19, 2025. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Sara Louise Hargrave, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institute 

of Health, 6701 Rockledge Drive, Room 

3170, Bethesda, MD 20892, (301) 443– 

7193, hargravesl@mail.nih.gov. 

Name of Committee: Social and 

Community Influences on Health 

Integrated Review Group; Social 

Psychology, Personality and 

Interpersonal Processes Study Section. 

Date: February 18–19, 2025. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health 

Rockledge II 6701 Rockledge Drive 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Joshua J. Matacotta, 

Psy.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 827–7498, 

josh.matacotta@nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Cell 

Signaling and Molecular Endocrinology 

Study Section. 

Date: February 18–19, 2025. 

Time: 10:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health 

Rockledge II 6701 Rockledge Drive 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting 

Contact Person: Latha Malaiyandi, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

812Q, Bethesda, MD 20892, (301) 435– 

1999, malaiyandilm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 


KHAMMOND on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 90, No. 11 / Friday, January 17, 2025 / Notices 5919 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 13, 2025. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2025–01097 Filed 1–16–25; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis; Panel PAR 22–069 High 

Impact, Interdisciplinary Science in NIDDK 

Research Areas (RC2). 

Date: March 7, 2025. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Tori Stone, Ph.D., 

Scientific Review Officer, National Institute 

of Diabetes and Digestive and Kidney, 

National Institute of Health, 6707 Democracy 

Boulevard, Rm 7013, Bethesda, MD 20892– 

5452, (301) 827–0994, tori.stone@nih.gov 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: January 14, 2025. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2025–01233 Filed 1–16–25; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Applied Therapeutics 

for Cancer Integrated Review Group; 

Advancing Therapeutics A Study Section. 

Date: February 13–14, 2025. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: Phoenix Park Hotel, 520 North 

Capitol St. NW, Washington, DC 20001. 

Meeting Format: In Person. 

Contact Person: Maureen Shuh, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 480–4097, maureen.shuh@

nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Clinical Informatics and Digital Health Study 

Section. 

Date: February 13–14, 2025. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Paul Hewett, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 

Bethesda, MD 20892, (240) 672–8946, 

hewettmarxpn@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neuronal Communications 

Study Section 

Date: February 13–14, 2025. 

Time: 9:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Prithi Rajan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive Bethesda, MD 

20892, (301) 435–1042, prithi.rajan@nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Interdisciplinary Clinical Care in Specialty 

Care Settings Study Section. 

Date: February 13–14, 2025. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Abu Saleh Mohammad 

Abdullah, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 827–4043, 

abuabdullah.abdullah@nih.gov. 

Name of Committee: Interdisciplinary 

Molecular Sciences and Training Integrated 

Review Group; Enabling Bioanalytical and 

Imaging Technologies Study Section. 

Date: February 13–14, 2025. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kenneth Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3218, 

MSC, 7717 Bethesda, MD 20892, 301–435– 

0229, kenneth.ryan@nih.hhs.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Cardiovascular and Respiratory Diseases 

Study Section. 

Date: February 13–14, 2025. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Raquel L VelazquezKronen, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Dr., 

Bethesda, MD 20892, (513) 301–9047, 

velazquezrl@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Lifestyle Change and Behavioral Health 

Study Section. 

Date: February 13–14, 2025. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Pamela Jeter, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 10J08 

Bethesda, MD 20892, (301) 827–6401, 

pamela.jeter@nih.gov. 


KHAMMOND on DSK9W7S144PROD with NOTICES